phenyl-n-tert-butylnitrone and Autoimmune Diabetes
phenyl-n-tert-butylnitrone has been researched along with Autoimmune Diabetes in 6 studies
Research
Studies (6)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Cui, WG; Hu, P; Hu, ZY; Lu, Q; Ma, L; Mei, QY; Xu, DY; Zhao, Q; Zhao, X; Zhou, DS; Zhou, WH | 1 |
Floyd, RA; Jacob, JM; Kotake, Y; Tabatabaie, T; Wallis, G | 1 |
Bray, TM; Chen, G; Ho, E | 2 |
Iovino, G; Kubow, S; Marliss, EB | 1 |
Floyd, RA; Graham, KL; Kotake, Y; Tabatabaie, T; Vasquez, AM | 1 |
Other Studies
6 other study(ies) available for phenyl-n-tert-butylnitrone and Autoimmune Diabetes
Article | Year |
---|---|
Secoisolariciresinol diglycoside, a flaxseed lignan, exerts analgesic effects in a mouse model of type 1 diabetes: Engagement of antioxidant mechanism.
Topics: Analgesics; Animals; Antioxidants; Butylene Glycols; Cyclic N-Oxides; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Flax; Glycosides; Hyperalgesia; Lignans; Male; Mice; Neuralgia; Sciatic Nerve; Spinal Cord; tert-Butylhydroperoxide | 2015 |
Spin trapping agent phenyl N-tert-butylnitrone protects against the onset of drug-induced insulin-dependent diabetes mellitus.
Topics: Animals; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Electron Spin Resonance Spectroscopy; Glycated Hemoglobin; Hyperglycemia; Islets of Langerhans; Male; Mice; Mice, Inbred BALB C; Nitrogen Oxides; Spin Trapping; Streptozocin; Weight Loss | 1997 |
Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice.
Topics: Acetylcysteine; Administration, Oral; Alloxan; Animals; Blood Glucose; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Free Radicals; Glutathione; Male; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrogen Oxides; Pancreas | 1999 |
Effect of alpha-phenyl-N-tert-butylnitrone on diabetes and lipid peroxidation in BB rats.
Topics: Animals; Cyclic N-Oxides; Diabetes Mellitus, Type 1; Female; Glucose Tolerance Test; Lipid Peroxidation; Male; Malondialdehyde; Nitrogen Oxides; Pancreas; Rats; Rats, Inbred BB; Spin Labels | 1999 |
Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes.
Topics: Alloxan; Animals; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Free Radicals; Hyperglycemia; Islets of Langerhans; Male; Mice; NF-kappa B; Nitrogen Oxides; Reactive Oxygen Species; Spin Labels; Streptozocin | 2000 |
Inhibition of the cytokine-mediated inducible nitric oxide synthase expression in rat insulinoma cells by phenyl N-tert-butylnitrone.
Topics: Acetylcysteine; Animals; Blotting, Northern; Cell Survival; Cyclic N-Oxides; Cytokines; Diabetes Mellitus, Type 1; Enzyme Induction; Enzyme Inhibitors; Free Radical Scavengers; Immunoblotting; Insulinoma; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Nitrogen Oxides; Protective Agents; Rats; RNA, Messenger; Thioctic Acid; Tumor Cells, Cultured | 2000 |